AstraZeneca PLC is 17.6x more valuable than GENMAB A/S by market capitalization ($286.27 B vs $16.27 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | GMAB | AZN |
|---|---|---|
| Market cap | $16.27 B | $286.27 B |
| US-listed rank | #699 | #45 |
| SEC filings | 540 | 1,004 |
AstraZeneca PLC is 17.6x more valuable than GENMAB A/S by market capitalization ($286.27 B vs $16.27 B).
Full pages: GENMAB A/S and AstraZeneca PLC, or browse the full rankings.